24.09.2014 • NewsCodexis

Codexis Appoints Kathleen Glaub to Board of Directors

Kathleen Sereda Glaub has been appointed to Codexis' board of directors. Her 30-year career in leadership positions with drug development and technology companies is expected to bring strong company-building and business strategy experience to the Codexis board.

Glaub has recently been appointed as CEO of Afferent Pharmaceuticals, a clinical-stage biotechnology company that is developing treatments for respiratory and urologic disorders and chronic pain, where she has been a member of its board of directors since 2013. Prior to Afferent, Glaub held positions at Plexxikon, Cell Genesys, Genentech, and Intel.

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.